Table 1.
Total (N = 89) | Transient (N = 15) | Persistent (N = 74) | |
---|---|---|---|
Gender, N (%) | |||
Male | 39 (44) | 12 (80) | 27 (36) |
Female | 50 (46) | 3 (20) | 47 (64) |
Age, years | 61.6 [52.6–68.7] | 56.6 [48.8–65.1] | 62.0 [53.3–68.9] |
Previous malignancy | |||
Yes | 45 (50) | 5 (33) | 40 (54) |
No | 44 (50) | 10 (67) | 34 (46) |
Subtype | |||
GGN | 63 (71) | 11 | 52 (70) |
PS | 26 (29) | 4 | 22 (30) |
Multiplicity | |||
Solitary | 60 (67) | 12 (67) | 48 (65) |
Multiple | 29 (33) | 3 (33) | 26 (35) |
Location, N (%) | |||
RUL | 32 (36) | 7 (47) | 25 (34) |
RML | 4 (4) | 2 (13) | 2 (3) |
RLL | 11 (12) | 1 (7) | 10 (13) |
LUL | 33 (37) | 3 (20) | 30 (41) |
LLL | 9 (10) | 2 (13) | 7 (9) |
Progressive, N (%) | 35 | N/A | 35 |
Diameter, mm | - | - | 10.4 [7.8–14.3] |
Volume, mm3 | - | - | 1530 [589–3220] |